Literature DB >> 19153169

Considerations for the processing and analysis of GoldenGate-based two-colour Illumina platforms.

A G Lynch1, M J Dunning, M Iddawela, N L Barbosa-Morais, M E Ritchie.   

Abstract

Illumina's GoldenGate technology is a two-channel microarray platform that allows for the simultaneous interrogation of about 1,500 locations in the genome. GoldenGate has proved a flexible platform not only in the choice of those 1,500 locations, but also in the choice of the property being measured at them. It retains the desirable properties of Illumina's BeadArrays in that the probes (in this case 'beads') are randomly arranged across the microarray, there are multiple instances of each probe and many samples can be processed simultaneously. As for other Illumina technologies, however, these properties are not exploited as they might be. Here we review the various common adaptations of the GoldenGate platform, review the analysis methods that are associated with each adaptation and then, with the aid of a number of example data sets we illustrate some of the improvements that can be made over the default analysis.

Mesh:

Year:  2009        PMID: 19153169     DOI: 10.1177/0962280208099451

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  9 in total

1.  Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis.

Authors:  Julien Laffaire; Sibille Everhard; Ahmed Idbaih; Emmanuelle Crinière; Yannick Marie; Aurelien de Reyniès; Renaud Schiappa; Karima Mokhtari; Khê Hoang-Xuan; Marc Sanson; Jean-Yves Delattre; Joëlle Thillet; François Ducray
Journal:  Neuro Oncol       Date:  2010-10-05       Impact factor: 12.300

Review 2.  Statistical approaches for the analysis of DNA methylation microarray data.

Authors:  Kimberly D Siegmund
Journal:  Hum Genet       Date:  2011-04-26       Impact factor: 4.132

3.  A statistical framework for Illumina DNA methylation arrays.

Authors:  Pei Fen Kuan; Sijian Wang; Xin Zhou; Haitao Chu
Journal:  Bioinformatics       Date:  2010-09-29       Impact factor: 6.937

4.  Identification and correction of previously unreported spatial phenomena using raw Illumina BeadArray data.

Authors:  Mike L Smith; Mark J Dunning; Simon Tavaré; Andy G Lynch
Journal:  BMC Bioinformatics       Date:  2010-04-27       Impact factor: 3.169

5.  The pitfalls of platform comparison: DNA copy number array technologies assessed.

Authors:  Christina Curtis; Andy G Lynch; Mark J Dunning; Inmaculada Spiteri; John C Marioni; James Hadfield; Suet-Feung Chin; James D Brenton; Simon Tavaré; Carlos Caldas
Journal:  BMC Genomics       Date:  2009-12-08       Impact factor: 3.969

6.  BeadDataPackR: A Tool to Facilitate the Sharing of Raw Data from Illumina BeadArray Studies.

Authors:  Mike L Smith; Andy G Lynch
Journal:  Cancer Inform       Date:  2010-09-29

7.  Unexpectedly low mutation rates in beta-myosin heavy chain and cardiac myosin binding protein genes in Italian patients with hypertrophic cardiomyopathy.

Authors:  Roberta Roncarati; Michael V G Latronico; Beatrice Musumeci; Stefania Aurino; Annalaura Torella; Marie-Louise Bang; Gloria Saccani Jotti; Annibale A Puca; Massimo Volpe; Vincenzo Nigro; Camillo Autore; Gianluigi Condorelli
Journal:  J Cell Physiol       Date:  2011-11       Impact factor: 6.384

8.  DNA methylation loci associated with atopy and high serum IgE: a genome-wide application of recursive Random Forest feature selection.

Authors:  Todd M Everson; Genevieve Lyons; Hongmei Zhang; Nelís Soto-Ramírez; Gabrielle A Lockett; Veeresh K Patil; Simon K Merid; Cilla Söderhäll; Erik Melén; John W Holloway; S Hasan Arshad; Wilfried Karmaus
Journal:  Genome Med       Date:  2015-08-21       Impact factor: 11.117

9.  DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival.

Authors:  Kathleen Conway; Sharon N Edmiston; Ryan May; Pei Fen Kuan; Haitao Chu; Christopher Bryant; Chiu-Kit Tse; Theresa Swift-Scanlan; Joseph Geradts; Melissa A Troester; Robert C Millikan
Journal:  Breast Cancer Res       Date:  2014-10-07       Impact factor: 6.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.